Article Details

Needham maintains Pacira BioSciences [PCRX] at Buy rating with a $76 price target

Retrieved on: 2021-01-08 14:40:11

Tags for this article:

Click the tags to see associated articles and topics

Needham maintains Pacira BioSciences [PCRX] at Buy rating with a $76 price target. View article details on hiswai:

Excerpt

During the last quarter, Renaissance Technologies LLC liquidated -70,700 of its shares in Pacira BioSciences Inc. while Macquarie Investment ...

Article found on: marketglobalist.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo